ReviewCurrent rheumatology reports2019
Takayasu Arteritis: Recent Developments.
Review in Current rheumatology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Therapeutic Management of Ocular Ischemia in Takayasu's Arteritis: A Case-Based Systematic Review.Frontiers in immunology · 2021Pooled it
- Large vessel vasculitis reframed: integrating conceptual shifts and evidence into practice for Takayasu arteritis and giant cell arteritis.Journal of rheumatic diseases · 2026Review
- Takayasu Arteritis and Giant Cell Arteritis: Results From a Cross-Sectional Study of 96 Italian Patients.Immunity, inflammation and disease · 2026Article
- Diagnostic delay and cardiovascular complications in Takayasu arteritis: a case-based review.Rheumatology international · 2025Review
- Takayasu Arteritis Following Necrotizing Fasciitis: A Case Report and Brief Review of the Literature.Cureus · 2025Article
- Overlap of Takayasu Arteritis and Kawasaki Disease in Infants.Chronic diseases and translational medicine · 2025Article
- Challenges in Diagnosis and Management of Takayasu Arteritis: A Case Report Highlighting Vascular Complications and Delayed Recognition.Clinical case reports · 2025Article
- Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu's arteritis.Arthritis research & therapy · 2025Article
- Cerebrovascular implications of takayasu arteritis: a review.Neuroradiology · 2025Review
- Successful delivery in pregnancy complicated by multiple Takayasu arteritis: a case report and clinical experience.Gynecology and pelvic medicine · 2025Article
- Functional and Practical Insights Into the Genetic Basis of Takayasu Arteritis.ACR open rheumatology · 2025Review
- Thrombosis in vasculitis: An updated review of etiology, pathophysiology, and treatment.Heliyon · 2024Review
- Article
- Asymptomatic Takayasu Arteritis With Critical Multivessel Stenosis.JACC. Case reports · 2024Article
- Review
- Guidelines for the standardized diagnosis and treatment of non-specific orbital inflammation (2024).International journal of ophthalmology · 2024Article
- Successful Use of Tofacitinib in Refractory Takayasu Arteritis: A Case Series.Mediterranean journal of rheumatology · 2023Article
- Tuberculosis and Takayasu arteritis: a case report.Journal of medical case reports · 2023Article
- Pathophysiology, Diagnosis, and Management of Takayasu Arteritis: A Review of Current Advances.Cureus · 2023Review
- A patient with Takayasu arteritis presenting with malignant hypertension: a case report.European heart journal. Case reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTakayasu arteritis (TA) is a granulomatous inflammatory disorder that affects large vessels, especially aorta and its proximal branches. Its diagnosis can be extremely challenging due to the non-specificity of the systemic inflammatory manifestations during the early phase of the disease and usually follows an insidious clinical course until the emergence of vascular ischemic complications. RECENT
findingsIts pathogenesis has been better delineated in recent years, especially the role of HLA-B
Indexed as
Identifiers
31321560What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.